Anticholinergic Exposure in Elderly Complex Chronic Patients: A Cross-Sectional Study

CONCLUSIONS: This study has highlighted clear differences between the scales used. DBI seems to be the scale that identifies a higher number of elderly chronic complex patients at risk of developing anticholinergic adverse effects.PMID:34463225 | DOI:10.2174/1381612827666210830164054

Source: Current Pharmaceutical Design - August 31, 2021 Category: Drugs & Pharmacology Authors: Ángela Tristancho-Pérez Ángela Villalba-Moreno Mar ía Dolores Santos-Rubio Mar ía Dolores López-Malo Bernardo Santos-Ramos Susana S ánchez-Fidalgo Source Type: research